Rapamycin and metformin combination treatment in a mouse model of type 2 diabetes, NONcNZO10/LtJ males, prevents hyperinsulinemia, normalizes insulin sensitivity, and reduces pathological complications of diabetes. This evidence concerns the gene INS and hyperinsulinism.